Gu F.X.
42
Coauthors
5
Documentos
Volumen de publicaciones por año
Cargando gráfico
| Año de publicación | Num. Publicaciones |
|---|---|
| 2007 | 3 |
| 2008 | 2 |
Publicaciones por áreas de conocimiento
Cargando gráfico
| Área de conocimiento | Num. Publicaciones |
|---|---|
| Cáncer | 6 |
| Nanopartícula | 1 |
| Biotecnología | 1 |
| Farmacología | 1 |
| Biomedicina | 1 |
Publicaciones por áreas temáticas
Cargando gráfico
| Área temática | Num. Publicaciones |
|---|---|
| Farmacología y terapéutica | 5 |
| Ingeniería y operaciones afines | 3 |
| Enfermedades | 2 |
| Química analítica | 1 |
| Química física | 1 |
| Medicina y salud | 1 |
Principales fuentes de datos
| Origen | Num. Publicaciones |
|---|---|
| Scopus | 5 |
| Google Scholar | 0 |
| RRAAE | 0 |
Cargando gráfico
Coautores destacados por número de publicaciones
| Coautor | Num. Publicaciones |
|---|---|
| Langer R.S. | 5 |
| Frank Alexis | 5 |
| Farokhzad O.C. | 5 |
| Zhang L. | 3 |
| Radovic-Moreno A.F. | 3 |
| Wang A.Z. | 3 |
| Basto P.A. | 2 |
| Jon S. | 2 |
| Bagalkot V. | 2 |
| Levy-Nissenbaum E. | 2 |
Cargando gráfico
Top Keywords
Cargando gráfico
Publicaciones del autor
Targeted nanoparticle-polypeptide bioconjugates for breast cancer therapy
Conference ObjectAbstract: Novel approaches that allow for a more effective and less toxic chemotherapy for disseminated breastPalabras claves:Docetaxel, HER2, Pla, Poly (lactic acid), Targeted nanoparticlesAutores:Basto P.A., Farokhzad O.C., Frank Alexis, Gu F.X., Langer R.S., Levy-Nissenbaum E., Radovic-Moreno A.F.Fuentes:scopusTargeted nanoparticles for cancer therapy
ArticleAbstract: Over the past decade, there has been an increasing interest in using nanotechnology for cancer theraPalabras claves:Autores:Farokhzad O.C., Frank Alexis, Gu F.X., Hong S., Karnik R., Langer R.S., Levy-Nissenbaum E., Wang A.Z.Fuentes:scopusCo-delivery of hydrophobic and hydrophilic drugsfrom nanoparticle-aptamer bioconjugates
ArticleAbstract: (Figure Presented) Herein we report a novel targeted drug delivery system consisting of nanoparticlePalabras claves:Antitumor agents, conjugation, Dual drug delivery, Nanoparticles, Targeted therapyAutores:Bagalkot V., Basto P.A., Farokhzad O.C., Frank Alexis, Gu F.X., Jon S., Langer R.S., Radovic-Moreno A.F., Zhang L.Fuentes:scopusSelf-assembled lipid-polymer hybrid nanoparticles: A robust drug delivery platform
ArticleAbstract: We report the engineering of a novel lipid-polymer hybrid nanoparticle (NP) as a robust drug deliverPalabras claves:drug delivery, Liposome, Nanoprecipitation, Polymeric nanoparticle, self-assemblyAutores:Chan J.M., Farokhzad O.C., Frank Alexis, Gu F.X., Langer R.S., Radovic-Moreno A.F., Rhee J.W., Wang A.Z., Zhang L.Fuentes:scopusSuperparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy
ArticleAbstract: (Chemical Equation Presented) Multifunctional superparamagnetic iron oxide nanoparticles: Herein wePalabras claves:doxorubicin, Nanoparticles, Superparamagnetic, TCL-SPIONAutores:Bagalkot V., Bander N.H., Cima M.J., Farokhzad O.C., Frank Alexis, Gu F.X., Jon S., Kantoff P.W., Langer R.S., Shaikh M., Vasilliou C.C., Wang A.Z., Yuet K., Zhang L.Fuentes:scopus